Leonardo Nicacio
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Leonardo Nicacio
Protara Therapeutics, Inc. reported in an 8-K filed June 29, 2026 that Leonardo Nicacio resigned as Chief Medical Officer, effective June 26, 2026. The proxy statement of Protara Therapeutics, Inc. reports total compensation of $1,382,483 for Leonardo Nicacio in fiscal 2025, including a base salary of $373,864.
“Protara Therapeutics, Inc. (the "Company") announced that Leonardo Viana Nicacio, M.D., Chief Medical Officer of the Company, resigned from the Company to explore other opportunities, effective as of June 26, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Protara Therapeutics, Inc. (TARA)
Proxy statement
Start not stated–2026-06-26
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Protara Therapeutics, Inc. (TARA) | Chief Medical Officer | $373,864 | $1,382,483 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.